Penumbra, Inc. (PEN)

338.78 +2.58 (+0.77%) USD  |  NYSE  |  Mar 17, 11:29
More

Penumbra EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for PEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Revvity, Inc. Upgrade
Rapt Therapeutics, Inc. (DELISTED) Upgrade
Abbott Laboratories Upgrade
Alphatec Holdings, Inc. Upgrade